|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from Operating Activities | |||||
| Loss for the year | |||||
| Adjustments to reconcile loss to net cash used in operating activities: | |||||
| Non-Cash Activities: | |||||
| Accrued issuance costs recorded in shareholders’ equity | |||||
| Shareholder debt waiver recognized as capital contribution | |||||
| Increase of lease liability and operating lease right-of-use asset due to lease modification (Note 9) | |||||
| Net cash used in operating activities | |||||
| Cash flows from Investing Activities | |||||
| Changes in short term deposits | |||||
| Purchase of fixed assets | |||||
| Proceeds from sales of marketable securities | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from Financing Activities | |||||
| Issuance of Ordinary Shares, net of issuance expenses | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Decrease in cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents and restricted cash at the beginning of the period | |||||
| Cash and cash equivalents and restricted cash at the end of the period | |||||
| Adjustments to reconcile loss to net cash used in operating activities: | |||||
| Share-based payment | |||||
| Depreciation | |||||
| Revaluation of marketable securities | |||||
| Exchange rate changes on cash and cash equivalents | |||||
| Changes in assets and liabilities: | |||||
| Decrease (increase) in trade receivables | |||||
| Decrease in other current receivables | |||||
| Increase (decrease) in trade payables | |||||
| Change in operating lease liability, net | |||||
| Increase (decrease) in other current payables | |||||
Loading...
